N/A
N=31
Suicide Prevention for Sexual and Gender Minority Youth (Open Trial)
Suicide
Bottom Line
View on ClinicalTrials.gov: NCT05087966 ↗Enrolled (actual)
31
Serious AEs
6.5%
Results posted
Mar 2024
Primary outcome: Primary: The Interpersonal Needs Questionnaire-15 (INQ-15) - Thwarted Belongingness — 30.83; 28.13; 29.36 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Safety Planning Intervention with Navigation Services (Behavioral)
- Age
- Pediatric, Adult · 15+ yrs
- Sex
- All
- Sponsor
- San Diego State University
- Primary completion
- Dec 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Interpersonal Needs Questionnaire-15 (INQ-15) - Thwarted Belongingness |
30.83; 28.13; 29.36 | — |
| PRIMARY Suicide-Related Coping Scale (SRCS) - Internal Coping Skills |
17.26; 18.83; 18.20 | — |
| PRIMARY Suicide-Related Coping Scale (SRCS) - External Coping Skills |
18.35; 19.79; 19.48 | — |
Summary
The overarching goal of this study is to develop a suicide prevention program for sexual-and-gender-minority youth and emerging adults. After development of the intervention program, an open phase trial will be conducted to test its feasibility, acceptability, and preliminary impact on three intervention targets.
Eligibility Criteria
Inclusion Criteria
- age 15 to 29 years; 2) identifies as gay, lesbian, bisexual, transgender, genderqueer, asexual, pansexual, non-binary, or another non-exclusively heterosexual identity, and/or reports same-gender romantic attraction, and/or reports same-gender sexual behavior in the past 12 months; 3) resides in San Diego County, California; 4) speaks English; 5) is willing and able to provide informed consent; 6) reports suicidal ideation over the past two weeks, as indicated by the clinician-administered Columbia-Suicide Severity Rating Scale (C-SSRS) Baseline version; and 7) reports a lifetime history of one or more suicide attempts.
Exclusion Criteria
- Individuals with immediate intention to attempt suicide will be excluded.
Data sourced from ClinicalTrials.gov (NCT05087966). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.